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Abstract 17 
Hemotrophic mycoplasmas (HM) are small, cell wall-less bacteria and infections are known 18 
for a wide range of animals. One possible indication of equine HM infection was given in 19 
1978, when a ‘haemobartonellosis’ outbreak was diagnosed in Nigerian horses by 20 
microscopy. However the first molecular proof of HM in horses was not reported until 2010, 21 
when a fragment of about 900 bp of the 16S rRNA of the equine HM was obtained. This 22 
sequence was used for development of a SYBR green I real-time PCR assay specific for 23 
equine HM. The lower detection limit of the PCR was ten 16S rDNA copy numbers per ml of 24 
blood. The newly designed assay was successfully applied for the detection and quantification 25 
of HM in horses in Germany. A high sample prevalence of 26.5% (95 % CI: 18.8-35.5%) was 26 
found (31 out of 117 horses). The mean bacterial load was 1.10 x 10
6
 16S rDNA copy 27 
number/ ml blood (range: minimum 1.05 x 10
3
, maximum 1.27 x 10
7
). Equine HM were also 28 
detected by microscopy (Giemsa and acridine orange stained blood smears), but results do not 29 
correlate very well with PCR results, as microscopy proved rather unspecific and not 30 
sensitive. In horses younger than one year, a significant correlation between PCR positive 31 
status and anemia was found. No correlation was found in PCR-positive animals older than 32 
one year. Therefore we assume that HM infection has a higher clinical relevance in young 33 
animals. 34 
 35 
 36 
Keywords 37 
Hemotrophic mycoplasma, horse, anemia, real-time PCR, SYBR green, prevalence, 38 
microscopic diagnostic. 39 
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1. Introduction 40 
Hemotrophic mycoplasmas (HM) are uniquely adapted bacteria causing epi- or intra-41 
erythrocytic infections in their hosts (Messick, 2004; Hoelzle 2008; Groebel et al., 2009). 42 
Formerly classified within the genera Haemobartonella and Eperythrozoon (order 43 
Rickettsiales) HM are now classified within the taxonomic class Mollicutes based on 44 
phylogenetic analysis of the 16S rRNA (Neimark et al., 2001). Infections with HM in pigs, 45 
cattle and cats are well-characterized and clinically marked by an overt life-threatening 46 
hemolytic anemia or a subtle chronic anemia, ill-thrift, infertility, lethargy, depression, weight 47 
loss, growth retardation in young animals and immune suppression. In horses the current 48 
knowledge about HM infections is rather restricted. Indications of HM infections in horses 49 
based on microscopic findings were reported in 1978 in Nigeria (Grettilat, 1978), and, 50 
recently, we found the first molecular proof of a novel HM isolate infecting horses. 51 
(Dieckmann et al., 2010). However, further studies are necessary to investigate the prevalence 52 
and significance of HM infections in horses. Since HM have never been cultivated so far, HM 53 
diagnosis relies mainly on microscopic and PCR techniques (Messick, 2004; Hoelzle, 2008). 54 
In the last years quantitative real-time PCR assays for the specific detection of several HM 55 
species have been established. (Hoelzle et al., 2007; Willi et al., 2009; Tasker et al., 2010).  56 
Aims of this study were the determination of occurrence of HM infections in horses, and 57 
evaluation of its clinical importance with regard to the induction of anemia. Therefore an 58 
equine HM specific quantitative SYBR green I real-time PCR assay for detection of equine 59 
HM in horse blood samples was developed. 60 
61 
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2 Material and Methods 62 
2.1 Samples 63 
For establishment of the SYBR green I real-time PCR assay, DNA from blood of two HM 64 
positive horses  (Dieckmann et al., 2010) and 66 HM negative horses collected from horses 65 
presented at the Clinic for Horses (Vetsuisse Faculty, University of Zurich) for unrelated 66 
purposes were included. These 66 animals had been analyzed for the presence of HM by a 67 
HM-specific universal SYBR green I real-time PCR assay (Willi et al., 2009). 68 
To screen for equine HM infections, EDTA-anti-coagulated blood samples of 117 horses 69 
originating from one breeding farm in Northern Germany with a known HM history 70 
(Dieckmann et al., 2010) were collected. This farm takes care of about 120 horses of different 71 
ages and breeds. Young horses (9 months to 2 years) were grouped according to their gender 72 
and age. During summer young horses are grazed in the marshlands of the river Weser. From 73 
October to April young horses are kept at the farm in barns with daily turn-out on pasture. 74 
Riding hoses and brood mares stay at the farm throughout the year. Blood samples were 75 
collected from 117 horses, thereof were: 70 mares (59.8%; 19 of them were pregnant 76 
(27.1%)), 17 geldings (14.5%) and 30 stallions (25.6%). Horses were of the age of 9 months 77 
to 26 years, mean age of horses was 4.3 years. 112 of the horses were warm blood breeds 78 
(95.7%); also there were two German riding ponies (1.7%), one tinker (0.9%), one 79 
thoroughbred (0.9%) and one pinto (0.9%) included into the study. Seven horses (6.0%) were 80 
reported with the following clinical preliminary report: poor nutritional condition, shaggy fur, 81 
poor performance. All horses were negative for Theileria,spp. Babesia spp., and Bartonella 82 
spp. infections by microscopy or culture, respectively.  83 
 84 
2.2 Laboratory examination of horse blood samples 85 
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Hematological parameters, i.e. hematocrit (Ht), hemoglobin (Hb), red blood cell count 86 
(RBCC), white blood cell count (WBCC), mean cell volume (MCV), mean cell hemoglobin 87 
(MCH) and mean cell hemoglobin concentration (MCHC), were determined (synlab.vet, 88 
Geesthacht, Germany) within 24 hours after sampling. Hematological parameters were 89 
analyzed using reference values (Cowell and Tyler, 2001; Merck Veterinary Manual; 90 
http://www.merckvetmanual.com/mvm/index.jsp?cfile=htm/bc/ref_00.htm). Hematocrit was 91 
used as parameter of anemia (Ht < 0.32 l/l indicates anemia, reference range: 0.32-0.48 l/l). 92 
Giemsa and acridine orange stained peripheral blood smears were prepared. 93 
 94 
2.3 DNA preparation 95 
Genomic DNA was extracted from 800 µl EDTA-anti-coagulated blood by a direct lysis 96 
method (Hoelzle et al., 2003). Pellets were then used to extract genomic DNA with the 97 
GenElute
TM
 Bacterial Genomic DNA Kit (Sigma-Aldrich Chemie GmbH, Buchs, 98 
Switzerland). Genomic DNA was eluted in 200 µl elution buffer and stored at -20°C until use. 99 
To monitor cross-contamination extraction controls consisting of PBS were performed 100 
accordingly within each batch of 12 samples. 101 
 102 
2.4 Standard DNA 103 
Plasmid DNA containing the partial 16S rRNA sequence of the equine HM isolate 30/7, 104 
(accession number FN421445) was used as standard DNA for determination of sensitivity of 105 
the assay and for quantification of HM (Dieckmann et al., 2010). Cloning was performed 106 
using the TOPO TA pCR2.1 cloning kit (Invitrogen, Basel, Switzerland), and the 30/7 107 
plasmid DNA was purified using the GenElute
TM
 Plasmid Miniprep Kit (Sigma-Aldrich) 108 
according to the manufacturer’s instructions. Purity and concentration of the plasmid were 109 
checked by agarose gel electrophoresis and optical density measurements (Biophotometer, 110 
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Vaudaux-Eppendorf). Plasmid size of pCR30/7 of 4.8 kb was used to calculate the 111 
concentrations in plasmid copies per micro liter corresponding to 16S rDNA copy numbers 112 
(CN) of the equine HM isolate. Dilutions of 10
6
, 10
5
, 10
4
 CN per reaction of the purified 113 
plasmid DNA were included as standard controls for HM quantification in each SYBR green I 114 
PCR run. Quantitative interpretation of the PCR results was obtained by the LightCycler
TM
 115 
software (Roche Diagnostics, Rotkreuz, Switzerland). The number of bacterial cells in horse 116 
blood samples was calculated as follows: 16S rDNA copy number per ml blood = average 117 
16S rDNA copy numbers (determined by LC software) x 50 (Hoelzle et al., 2007). 118 
 119 
2.5 SYBR green I real-time PCR assay 120 
Primers were designed for amplification of a 107 bp product of a 16S rRNA region specific 121 
for the equine HM isolate (Dieckmann et al., 2010) using the ARB probe design tool (Ludwig 122 
et al., 2004). Therefore 16S rRNA sequences of hemotrophic mycoplasmas, non-hemotrophic 123 
mycoplasmas and non-mycoplasmal organisms were integrated into an ARB database, aligned 124 
using the ClustalW tool and the alignment was refined manually. At least two mismatches in 125 
the forward or reverse
 
primer sequence were found when aligned with the 16S rRNA of 126 
nearly all HM
 
species and other bacteria. However, no mismatches were found with the 127 
16S rRNA of the bovine species ‘Candidatus M. haemobovis’, as it is nearly identical to the 128 
16S rRNA of the equine HM. Accession numbers, primer sequences and part of the alignment 129 
are shown in Table 1. Primer binding specificities were tested using pDRAW32 130 
(www.acaclone.com; Tippmann, 2004) and primer sequences were searched for sequence 131 
homologies using the BLAST tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi; Altschul et al., 132 
1997). Primers were purchased from Eurofins MWG Operon (Ebersberg, Germany). 133 
The LightCycler
TM
 2.0 System (Roche) was used in combination with the LightCycler
®
 134 
FastStart DNA Master
PLUS
 SYBR green I master mix kit (Roche). Each glass capillary 135 
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contained 15 µl of master mix (10 µl water, 1 µl primer mix (0.25 µM each), 4 µl premixed 136 
master mix (5x)) and 5 µl of extracted template DNA. Cycling conditions were as follows: 137 
preincubation (15 min at 95°C) and 45 cycles of amplification (10 sec 95°C, 5 sec 55°C, 138 
20 sec 72°C). A melting curve was generated using the following settings: heating from 65°C 139 
to 95°C with a ramp rate of 0.1°C per sec. A no template control (water) was included in each 140 
run to check for contamination. 141 
The assay was evaluated as positive, if two criteria were fulfilled: first, an exponential 142 
increase in fluorescence acquisition during the first 32 cycles of PCR (CP < 32). Samples with 143 
crossing points of 32 to 35 cycles were repeated to verify results. If the CP values were 144 
consistently lower than 35 cycles, the sample would be regarded as positive. Second, the 145 
melting temperature (TM) curve showed a distinct peak at TM = 81 ± 1°C. If the curve was not 146 
distinct and/ or a certain TM determination was not possible, the samples were repeated to 147 
verify results. If no amplification occurred, the CP values were > 35 cycles or no distinct TM 148 
curve could be obtained, the PCR reaction was assigned as negative. In all runs the positive 149 
controls (pCR30/7 pCR plasmid DNA) were positive and the no template controls (water) 150 
were negative. Only PCR runs fulfilling these criteria were taken into consideration. 151 
 152 
2.6 Determination of specificity and sensitivity of the new designed SYBR green I real-153 
time PCR assay 154 
Specificity of the assay was tested using DNA from equine HM isolates (Dieckmann et al., 155 
2010) and HM negative horse samples (n = 66). Other bacterial DNA samples used for 156 
specificity testing are listed in Table 2. 157 
The analytical lower limit of detection (LOD) of the SYBR green I PCR assay was 158 
determined. Therefore pCR30/7 plasmid DNA was spectrophotometrically quantified and 159 
DNA concentrations were adjusted to 53 pg representing 10
7
 CN. Ten-fold serial dilutions 160 
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were analyzed in triplicate. The pCR30/7 plasmid DNA was calculated as 5.3 ag (attogram) 161 
per copy (genome weight = genomic length (bp) x 665 Da/bp x 1.67 x 10
-24
 g/Da (Hoelzle et 162 
al., 2007), size of pCR30/7 plasmid = 4.8 kb). 163 
 164 
2.7 Determination of intra- and inter-assay variations 165 
Evaluation of the reproducibility of the crossing point (CP) values and melting temperatures 166 
(TM) were performed by analysis of the coefficient of variation (CV). For testing the intra-167 
assay variation, three standard series of pCR30/7 plasmid DNA (10
7
 to 10
1
 CN) were tested 168 
within one run. Inter-assay variations were determined by performing three standard curves of 169 
pCR30/7 plasmid DNA (10
7
 to 10
1
 CN) on different days. 170 
 171 
2.8 Gel electrophoresis, DNA sequencing and sequence analysis 172 
To verify the amplicons the SYBR green I real-time PCR were completely applied on a 2% 173 
agarose gel. PCR products were excised from the gel, purified using the QIAquick Gel 174 
Extraction Kit (Qiagen AG, Hombrechtikon, Switzerland), cloned (TOPO TA Cloning Kit, 175 
Invitrogen) according to the manufacturer’s instructions and sequenced (Eurofins MWG 176 
Operon). Sequences were searched for homologies using the BLAST tool 177 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi; Altschul et al., 2007). 178 
 179 
2.9 Statistical analysis 180 
Data were compiled and analyzed using Excel (Microsoft, Wallisellen, Switzerland) and R 181 
Foundation for Statistical Computing (R version 2.11.1; Vienna, Austria). For observed 182 
prevalence 95% confidence intervals (CI) were calculated. Categorical values (gender, 183 
anemia, clinical status, pregnancy, type of housing) were analyzed by Fisher’s exact test and 184 
continuous variables (age, hematological parameter) by the Mann-Whitney U-test. Correlation 185 
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of hematocrit and blood loads was assessed by the spearman rank correlation coefficient (rs). 186 
Differences were considered statistically as significant, if P  0.05. 187 
 188 
2.10 Nucleotide sequence accession numbers 189 
The nucleotide sequences have been deposited at GenBank with accession number FR668084, 190 
FR668085 and FR668086. 191 
192 
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3. Results 193 
3.1 Evaluation of the SYBR green I real-time PCR assay  194 
The SYBR green I real-time PCR assay reacted positive with DNA from equine HM isolated 195 
from horse blood. Also cross-reaction with ‘Candidatus M. haemobovis’ was observed as 196 
expected. Neither other HM, nor non-HM species, nor non-mycoplasmal organisms gave a 197 
positive signal (Table 2). Additionally, all universal HM PCR negative horses (n = 66) reacted 198 
negative in the novel SYBR green I real-time PCR assay. Presence or absence and size of 199 
amplified DNA (107 bp) derived by the SYBR green I real-time PCR assay was confirmed by 200 
agarose gel electrophoresis (Fig. 1) and amplicon specificity of the positive control was 201 
verified by sequencing showing an overall identity of 100% with the primer spanned region. 202 
Sequencing of three selected PCR products revealed sequences of 105-106 bp showing an 203 
identity of 99-100% to Mycoplasma sp. horse isolate 30/7 (Acc. no. FN421445) and 96-98% 204 
identity to ‘Candidatus M. haemobovis’ (Acc. no. EF460765).  205 
For analysis of sensitivity ten-fold serial dilutions of pCR30/7 plasmid DNA ranging from 206 
5.3 ag to 53 pg (corresponding to 10
0
 to 10
7
 CN) per reaction were tested in the SYBR green I 207 
real-time PCR assay. PCR reacted positive if at least 10 CN/ ml blood were present. 208 
Intra- and inter-assay variations were measured to determine the reproducibility of the SYBR 209 
green I real-time PCR assay. The coefficients of variation of CP and TM values for the intra- 210 
and inter-assay variations are presented in Table 3. 211 
 212 
3.2 Evaluation of significance of HM infection in horses by SYBR green I real-time PCR  213 
To evaluate the significance of HM infection in horses, 117 blood samples of anemic and 214 
non-anemic horses were tested. Thirty-one horse blood samples (26.5%; 95% CI: 18.8-35.5%) 215 
revealed a positive SYBR green I real-time PCR result showing a mean crossing point of 216 
CP = 32.28 ± 1.44 (range: minimum 29.43, maximum 34.69) and a mean melting temperature 217 
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of TM = 80.88 ± 0.37 °C (range: minimum 80.16, maximum 81.78). Nine horses showing an 218 
anemia (Ht < 0.32; 9/23, 39.%), ten horses with a low level hematocrit (Ht = 0.32-0.34; 10/38, 219 
26.3%) and twelve non-anemic horses (Ht > 0.34; 12/56, 21.4%) exhibited positive PCR 220 
results. 221 
All equine blood samples that tested positive by the newly designed SYBR green I real-time 222 
PCR assay were further analyzed for HM quantification. The overall mean bacterial load was 223 
1.10 x 10
6
 16S rDNA copy number/ ml blood (range: minimum 1.05 x 10
3
, maximum 224 
1.27 x 10
7
). In anemic and PCR positive horses a mean bacterial load of 1.10 x 10
6
 16S rDNA 225 
copy number/ ml blood (range: minimum 1.28 x 10
3
, maximum 4.15 x 10
6
) was observed and 226 
in non-anemic and PCR positive horses a mean bacterial load of 1.42 x10
5
 16S rDNA copy 227 
number/ ml blood (range: minimum 1.05 x 10
3
, maximum 1.27 x 10
7
) was detected. In the 228 
group of horses (n = 7) with the preliminary report of showing a reduced performance 229 
condition, having a shaggy fur and being meager, two horses showed a positive PCR signal 230 
(28.6%; 95% CI: 3.7-71.0%) with a mean bacterial load of 4.65 x 10
3
 16S rDNA copy 231 
number/ ml blood (range: minimum 1.05 x 10
3
, maximum 8.25 x 10
3
). 232 
 233 
3.3 Hematological findings 234 
Ht, Hb, RBCC, WBCC, MCV, MCH and MCHC were analyzed and compared to reference 235 
values (Table 4). Twenty-three of 117 horses (28.2%) were anemic (Ht < 0.32), whereas 38 236 
more horses (32.5%) showed a low level Ht within the reference range (0.32-0.34 l/l). Mean 237 
Ht was 0.34 l/l. Mainly young horses (< 1 year) were affected from low Ht values. They 238 
mostly showed a low level Hb concentration and a low level RBCC, too. Mean Hb of all 239 
animals (n = 117) was 128 g/l and mean RBCC was 8.80 x 10
12
 cells/l. Some horses exhibited 240 
a leucocytosis. The overall (n = 117) mean WBCC was 9.6 x 10
9
 cells/l. Mean MCV was 241 
39.47 fl, mean MCH 14.67 pg and mean MCHC 37.26 g/dl (Table 4). 242 
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 243 
3.4 Characteristics of HM PCR-positive horses 244 
Looking at the complete population investigated, PCR-positive horses had significantly lower 245 
RBCC and MCHC than PCR-negative horses (P ≤ 0.05; Table 4; Fig. 3). In addition, Ht and 246 
Hb tended to be lower in PCR-positive horses compared with PCR-negative animals (Table 247 
4). No significant difference was found in WBCC, MCV and MCH. However, in horses 248 
< 1 year, Ht, Hb, and RBCC were significantly lower in PCR-positive compared with PCR-249 
negative horses (P ≤ 0.05; Table 4; Fig. 3), whereas MCV and MCH were significantly 250 
elevated in PCR-positive horses < 1 year (P ≤ 0.05; Table 4). In contrast, in PCR-positive 251 
animals > 1 year all measured blood parameters were not significantly different compared 252 
with PCR-negative horses. PCR-positive horses < 1 year showed significantly lower Ht and 253 
Hb values (P < 0.0001) as well as lowered MCV and MCH than PCR-positive horses > 1 year 254 
(P = 0.0005 and P < 0.0001, respectively) and a significantly higher WBCC (P ≤ 0.05), but 255 
not a significantly changed RBCC (Fig. 4). No significant correlations between bacterial 256 
blood loads and blood parameters could be found (assessed by the spearman rank correlation 257 
coefficient rs). PCR-positive status of the overall population independent from age was not 258 
significantly associated with anemia. However, in horses < 1 year anemia was associated with 259 
infection. In general, PCR-positive and PCR-negative horses showed no significant 260 
differences in age, gender, pregnancy and clinical health status.  261 
 262 
3.5 Comparison of SYBR green I real-time PCR results to microscopic detection methods 263 
Results of SYBR green I real-time PCR assay were compared to results of microscopy of 264 
Giemsa and acridine orange stained peripheral blood smears (Fig. 2). Forty-six of 117 265 
samples (39.3%) revealed HM in peripheral blood smears stained with either Giemsa or 266 
acridine orange. In 17 Giemsa (14.5%) and in 44 acridine orange (37.6%) stained horse blood 267 
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smears HM were detected as coccoid structures of approx. 0.3-0.4 µm in size closely attached 268 
to the surface of RBCs. In fifteen samples (12.8%) HM could be detected in both staining 269 
techniques and 71 samples (60.7%) were negative in both staining techniques. 270 
Twenty-five of 46 samples microscopically diagnosed as HM positive (either Giemsa or 271 
acridine orange stained) were confirmed as positive by PCR (54.3%). In 71 microscopically 272 
HM-negative samples, six reacted positive in PCR (8.5%). This corresponds to a rate of false-273 
positive microscopic results of 23.3% and false-negative microscopic results of 19.4%.  274 
 275 
4. Discussion 276 
Although the first possible evidence of equine HM infections was described a long time ago 277 
by microscopy (Grettilat, 1978) our knowledge of HM in horses is rather limited. Recently the 278 
molecular confirmation of HM in horses was published for the first time (Dieckmann et al., 279 
2010). 280 
In this study we describe the development of the first SYBR green I real-time PCR assay for 281 
the sensitive and specific detection of HM in the blood of horses and the application of the 282 
assay for the detection of HM in a horse population in Germany and analysis of its clinical 283 
importance. Formerly the diagnosis of HM infections was based on the microscopic detection 284 
in chemically stained blood smears – a method which is not specific and sensitive enough to 285 
detect animals with low bacterial blood loads (Hoelzle, 2008; Ritzmann et al., 2009). For 286 
other HM species, e.g. M. haemofelis, M. suis, M. haemocanis and ‘Candidatus 287 
M. turicensis’, the establishment of specific and sensitive real-time PCR methods has 288 
delivered valuable insights into the significance of HM infections in cats, dogs and pigs 289 
(Hoelzle et al., 2007; Barker et al., 2010; Willi et al., 2009). Accordingly the reliable 290 
quantitative detection of HM infections in horses is the crucial step for the evaluation of the 291 
actual significance of equine HM. Our newly developed SYBR green I real-time PCR assay 292 
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demonstrated a sensitivity of 10 CN/ ml blood. The analytical specificity of the SYBR green I 293 
real-time PCR was confirmed by testing DNA from different bacteria (mycoplasmas and 294 
other bacteria with clinical relatedness). As predicted in silico only cross reactivity was found 295 
with the ‘Candidatus M. haemobovis’ DNA. 296 
Comparison of the PCR and microscopic results revealed a poor correlation. To some extent 297 
microscopically positive tested animals reacted negative in PCR and vice versa. False-298 
negative microscopic detection may result from low bacterial loads or inapparent infections 299 
with bacteria being absent from blood, whereas false-positive microscopic results are because 300 
of confusion of HM with Howell-Jolly or Heinz bodies, background debris and staining 301 
artifacts (Hoelzle 2008). It was reported earlier that blood loads of 4.4 x 10
6
 ‘Candidatus 302 
M. turicensis’ copies/ ml blood correspond to only one bacterium per 103 to 104 RBCs 303 
(Museux et al., 2009). Bacterial blood loads of affected horses in this study were in the same 304 
range hindering the unambiguous identification of HM on the surface of RBCs by 305 
microscopy. Using the newly designed SYBR green I real-time PCR assay an unambiguous 306 
and sensitive detection of HM in blood of affected horses was possible. The possibility of 307 
false-positive or false-negative SYBR green I real-time PCR results is negligible due to its 308 
high specificity and sensitivity. However, it remains difficult to establish a novel diagnostics 309 
tool, when a good reference method is missing. Thus, assignment of positive and negative 310 
predictive values was hampered. 311 
The HM prevalence in the horse population investigated in this study was 26.5% (95% CI: 312 
18.8-35.5%). Analogically high HM prevalences of 22.3% and 18.6%, respectively, were 313 
found in cattle without apparent clinical signs in Japan (‘Candidatus M. haemobovis’, 314 
Tagawa et al., 2010) and in alpacas in Switzerland (Kaufmann et al., 2010). In comparison, 315 
prevalences of feline (0.5 to 8.5%; Willi et al., 2006) and canine HM in Switzerland (1.2%; 316 
Wengi et al., 2008) are considerably lower. Since our study includes horses of only one farm 317 
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the general prevalence and pathogenic potential of equine HM cannot be assessed on the basis 318 
of the present data. Further studies are necessary to determine the actual prevalence and 319 
whether the found HM infections may be a regional phenomenon or a single-herd, sporadic 320 
event. 321 
Younger horses seem to be more affected by an equine HM infection. Though red blood cell 322 
count (RBCC) and mean cell hemoglobin concentration (MCHC) were significantly lowered 323 
in all PCR-positive animals. RBCC, hematocrit (Ht), hemoglobin (Hb), mean cell volume 324 
(MCV) and mean cell hemoglobin (MCH) were significantly lowered in infected animals 325 
< 1 year, but not in infected horses > 1 year (Table 4). However, changes are mostly within 326 
the normal range, but at a low level. As the number of samples in each group highly differs, 327 
the calculated statistics should be viewed with caution. Therefore, this correlation in horses 328 
<1 year old should be investigated in future studies of whether an equine HM infection has a 329 
more severe course of disease in young horses, as it was described for HM infection in llamas 330 
(Reagan et al., 1990) and sea lions (Volokhov et al., 2011). When interpreting changes in 331 
blood parameter, one have to be aware, that blood counts of young horses may generally 332 
differ from older horses (Harvey et al., 1984; Tyler et al., 1987; Cowell and Tyler, 2001) but 333 
no distinct reference ranges for younger horses are given. Reference ranges can slightly vary 334 
from country to country and from race to race (especially for drafting horses, thoroughbreds, 335 
and ponies (Harvey et al., 1984; Tyler et al., 1987; Cowell and Tyler, 2001; Fey, 2006;). 336 
Differences in blood counts of young animals may also be affected by higher possibility of 337 
intestinal parasites. Overall looking at the entire population independent of age, equine HM 338 
infection was not associated with anemia and blood loads do not correlate with Ht values. 339 
Absence of correlation of anemia and HM infection was also reported for feline HM (Willi et 340 
al., 2006) whereas M. suis infection in pigs is often accompanied by severe anemia and strong 341 
correlation of Ht, Hb and RBCC (Hoelzle, 2008; Ritzmann et al., 2009).  342 
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In horses, HM infection most often seems to have a subclinical or asymptomatic course of 343 
disease showing only low bacterial loads in blood. For this reason detection of HM in horse 344 
blood as well as assignment of a distinct clinical manifestation is complicated. Mostly, horses 345 
only show unspecific clinical signs like slimming, shaggy fur, apathy and a bad general 346 
performance.  347 
HM were detected by SYBR green I real-time PCR in healthy horses without any clinical 348 
signs and without showing abnormalities in the blood count. A similar situation was reported 349 
for ‘Candidatus M. haemolamae’ and M. haemocanis. Disease and anemia seem to be 350 
developed only by stressed, immunocompromised or co-infected animals (Messick, 2004 351 
Tornquist et al., 2009). For M. wenyonii it was described that clinical signs were more present 352 
in combination with concurrent infections with Anaplasma marginale (Hofmann-Lehmann et 353 
al., 2004). An undulating course of infection alternating between pronounced clinical signs 354 
and an asymptomatic stage was described for feline HM and M. suis (Hoelzle, 2008; Willi et 355 
al., 2006).  356 
Interestingly, infections of cattle herds with a rather similar HM species (‘Candidatus 357 
M. haemobovis’) were reported in the same region (Hoelzle et al., 2011). Both, equine and 358 
bovine HM isolates, exhibits high 16S rRNA sequence identity (97-98%). According to the 359 
cut-off values (Drancourt and Raoult, 2005) this sequence difference may be not enough for 360 
designation of a novel species. Therefore it could be speculated that the equine HM isolate 361 
and ‘Candidatus M. haemobovis’ could be one species cross-infecting cattle and horses. Host 362 
specificity of mycoplasmas was recently questioned (Pitcher and Nicholas, 2005). In respect 363 
of historical reasons HM species were named after the animal species they were isolated from. 364 
A similar situation as in horse and cattle is given with M. haemofelis (cat) and M. haemocanis 365 
(dog), which shows a 16S rRNA sequence identity of 99.3-99.7%, but only 94.3-95.5% 366 
sequence identity of the RNase P (rnpB) gene (Peters et al., 2008; Sykes et al., 2005). Further 367 
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phylogenetic analyses (e.g. sequencing of the rnpB gene) and cross-infectivity studies are 368 
necessary to determine if the novel equine HM isolate is an independent species with the 369 
proposed designation ‘Candidatus Mycoplasma equi’. Unfortunately amplification and 370 
sequencing of the full length 16S rRNA and the rnpB gene failed during this study as well as 371 
in our previous study (Dieckmann et al., 2010). 372 
In conclusion we confirmed HM infections in Northern Germany using our newly designed 373 
SYBR green I real-time PCR assay. The clinical significance of equine HM infections still 374 
remains difficult to interpret and only in horses younger than one year equine HM infection 375 
was associated with anemia. More investigations in the field of clinical characterization of 376 
this novel infection in horses have to be done in future to establish a clear clinical picture and 377 
to examine the pathogenic potential of HM infection in horses. The herein developed SYBR 378 
green I real-time PCR assay provides an important prerequisite for doing so. 379 
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Figure captions 498 
Fig. 1. SYBR green I real-time PCR assay of 10 samples applied on an 2% agarose gel. An 499 
amplicon of the corresponding size of 107 bp was obtained in PCR positive horses 500 
(lane 3 = no. 90; 4 = no. 103; 5 = no. 108; 6 = no. 111; 7 = no. 114; 9 = no. 126; 10 = no. 127) 501 
and amplification was absent in no template control (lane no. 1) and PCR negative horses 502 
(lane 2 = no.86; lane 8 = no. 117). 100 bp ladder (lane 11) was used for accession of amplicon 503 
sizes. 504 
 505 
Fig. 2. Micrographs of Giemsa (A) and acridine orange (B) stained peripheral blood smears 506 
(magnification 1000x) of a horse infected with hemotrophic mycoplasmas. Roundish particles 507 
of approx. 0.3-0.4 µm in size are detected on the surface of red blood cells in both staining 508 
techniques. In Giemsa stained blood smear it can be seen, that some hemotrophic 509 
mycoplasmas are laying in small grooves on the surface of the erythrocytes. 510 
 511 
Fig. 3. Blood parameters ((A) hemoglobin, (B) hematocrit, (C) red blood cell count, (D) white 512 
blood cell count) of PCR positive (PCR pos) and PCR negative (PCR neg) horses are 513 
presented as box plots. Results are shown for all horses and for horses grouped according to 514 
their age (< 1 year, > 1 year). Boxes extend from the 25
th
 to the 75
th
 percentile, median is 515 
presented as horizontal line and the bars extend to the minimum and maximum value. Dots 516 
represent outliers. Values from PCR-positive and PCR-negative horses were analyzed for 517 
significant differences using the Mann-Whitney U-test. P-values are listed in Table 4. 518 
 519 
Fig. 4. Comparison of correlation between blood parameters ((A) hemoglobin, (B) 520 
hematocrit, (C) red blood cell count, (D) white blood cell count) and bacterial load in PCR 521 
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positive horses > 1 year (n = 23) and PCR positive horses < 1 year (n = 8)). Grey boxes 522 
indicate the corresponding reference ranges according to Cowell and Tyler (7).  523 
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Table 1. Alignment of primer sequences with target and non target species 16S rRNA sequences of closely related organisms 1 
Species Forward primer 5‘-3‘ Reverse primer 5‘-3‘ Acc. No. 
Primer sequence CAGGCGGATGTGTAAGTTC CGCCTCCGGTGTTCTTAAAC  
Novel equine HM isolate 30/7 ------------------- -------------------- FN421445 
‘Candidatus Mycoplasma haemobovis’ ------------------- -------------------- EU367965 
Mycoplasma haemofelis ------------------- ------T-----------G- AY150984 
‘Candidatus Mycoplasma haemominutum’ T-------CAAA–TGA-CT A-----T-------C–C--T DQ157149 
‘Candidatus Mycoplasma turicensis’ ----------AA------- ------T------------T DQ825450 
Mycoplasma haemomuris ---------TG-------- ------T---------G--T U82963 
Mycoplasma coccoides ----------AAC------ ------T------------T AY171918 
Mycoplasma suis T----T–-A----GTA-C- A-----T-------C–C--T U88565 
Mycoplasma wenyonii T------GGAG--TGA-C- A-----T-------C–C--T AF016546 
Mycoplasma ovis T------GGAG-CTGA-C- A-----T-------C–C--T AF338268 
‘Candidatus Mycoplasma haematoparvum’ T-------CAA--TGA-GT A-----T-------C-CCA- AY532390 
‘Candidatus Mycoplasma haemodidelphis’ T-------CAGTCTGA-C- -----TT-------C–C--T AF178676 
‘Candidatus Mycoplasma kahanei’ T-------GAGT–TGA-CT A-----T-------C–C--T AF338269 
‘Candidatus Mycoplasma haemolamae’ T---T---G–A--TGA-C- A-----T-------C–C--T AF306346 
Mycoplasma pneumoniae ---------TGAA----CT ----A-T-------C–TC-T NC_000912 
Mycoplasma arginini T----T–T-TAT-----CT -----TT---------CC-T M24579 
Mycoplasma penetrans ---------T-AC----CT ------T---------CC-T NC_004432 
Escherichia coli -------T-TGT-----CA ----A-----A---C–CC-G U18997 
Bacillus cereus ----T--T-TCT-----CT ----A-T-------C-CC-T AY138272 
Bacillus subtilis -------T-TCT-----CT ----A-T-------C-CC-T AB042061 
Salmonella enterica -------T-TGT-----CA ----A-----A---C–CC-G U92197 
Bartonella quintana T--------ATT-----CA ----A-T-------C-CCGA BX897700 
Streptococcus equi -------T-TGA-----CT ----A---------C–CC-T DQ303186 
Clostridium perfringens T---------AT-----GG ----A-T---------CCTA AB045286 
Only bases different to primer sequences are shown 2 
Table
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Table 2. Bacterial strains used for evaluation of specificity of the newly designed SYBR green I real-time PCR assay 3 
Species Origin Result 
Horse isolate No. 30/7 Field strain
a
 Positive 
Horse isolates Field samples, n = 117 31 positive 
Horse blood controls Field samples
b
, n = 66 Negative 
‘Candidatus Mycoplasma haemobovis’ Field strainsc, n = 6 Positive 
Mycoplasma haemofelis 
d
 Negative 
Mycoplasma haemominutum 
d
 Negative 
‘Candidatus Mycoplasma turicensis’ d Negative 
Mycoplasma wenyonii Field strains
c
, n = 4  Negative 
Mycoplasma suis Strain 3808
e
 Negative 
Mycoplasma suis Strain 3806
e
 Negative 
Mycoplasma suis Strain 146
e
 Negative 
‘Candidatus Mycoplasma haemolamae’ Field strainsf, n = 5 Negative 
Mycoplasma arginini 
g 
Negative 
Mycoplasma penetrans 
g 
Negative 
Mycoplasma pneumoniae Sebastian Schmidl
h
 Negative 
Bacillus cereus isolated from horse
g
 Negative 
Bartonella bacilliformis Christoph Dehio
i
 Negative 
Bartonella henselae Christoph Dehio
i
 Negative 
Bartonella quintana ‘Fuller’ Christoph Dehioi Negative 
Bartonella quintana ‘Toulouse’ Christoph Dehioi Negative 
Bartonella tribocorum Christoph Dehio
i
 Negative 
Clostridium perfringens Type A isolated from horse
g
 Negative 
Escherichia coli isolated from horse
g
 Negative 
Salmonella sp. isolated from horse
g
 Negative 
Streptococcus equi isolated from horse
g
 Negative 
a
 Field strain isolated from an anemic horse (Dieckmann et al., 2010), used as positive control for the SYBR green I real-time PCR assay (see material and methods); 
b
 DNA of 4 
horse blood samples collected from horses presented at the Clinic for Horses, Equine Department, Vetsuisse Faculty, University of Zurich, for unrelated purposes; negative for 5 
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any HM infection (SYBR green I real-time PCR assay covering any HM species (Willi et al., 2009)); 
c
 Field strains isolated from anemic cattle (Hoelzle et al., 2011); 
d
 DNA of 6 
three feline HM isolates from anemic cats (Willi et al., 2006); 
e
 Blood from splenectomized pigs experimentally infected with M. suis (Felder et al., 2012); 
f
 Field strains isolated 7 
from anemic alpacas (Institute of Veterinary Bacteriology, University Zurich); 
g
 Strain collection of Institute of Veterinary Bacteriology; 
h
 provided by Sebastian Schmidl 8 
(Department of General Microbiology, Georg-August-University of Göttingen); 
i
 DNA provided by Christoph Dehio (Infection Biology, Biozentrum, University of Basel). 9 
10 
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Table 3. Inter-assay and intra-assay reproducibility of the newly designed SYBR green I real-time PCR assay 11 
 Inter-assay variation Intra-assay variation 
Copy 
number
a
 
Mean CP  
(± SD)
b
 
CV (%)
c
 
Mean TM  
(± SD)
b
 
CV (%) 
Mean CP 
 (± SD)
b
 
CV (%) 
Mean TM  
(± SD)
b
 
CV (%) 
10
7
 CN
d
 22.46 ± 0.032 0.143 81.19 ± 0.092 0.126 22.34 ± 0.097 0.435 81.32 ± 0.031 0.038 
10
6 
CN 26.32 ± 0.233 0.885 81.17 ± 0.076 0.093 26.21 ± 0.010 0.038 81.26 ± 0.030 0.037 
10
5 
CN 28.89 ± 0.586 2.029 81.19± 0.025 0.031 29.10 ± 0.127 0.435 81.18 ± 0.025 0.031 
10
4 
CN 26.57 ± 0.385 1.449 81.17 ± 0.040 0.050 26.36 ± 0.537 2.036 81.20 ± 0.015 0.019 
10
3 
CN 32.78 ± 2.874 8.766 81.26 ± 0.096 0.119 34.28 ± 0.212 0.619 81.30 ± 0.057 0.070 
10
2 
CN 28.24 ± 2.517 8.914 81.20 ± 0.121 0.150 28.02 ± 2.564 9.151 81.38 ± 0.038 0.047 
10
1 
CN 31.37 ± 3.097 9.873 81.22 ± 0.339 0.418 33.56
 
± 2.120 3.211 81.46 ± 1.558 2.036 
a
 Copy number were calculated from spectrophotometrically quantified DNA as described in the material and methods section; 
b
 Mean crossing point (CP), mean melting 12 
temperature (TM) and standard deviations (SD) were calculated from triplicates of each concentration; 
c
 coefficient of variation; 
d
 16S rDNA copy numbers (CN). 13 
14 
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Table 4. Hematological values of PCR-positive and PCR-negative horses 15 
 PCR positive (n = 31) PCR positive (n = 31)   
Parameter Median 95% CI
a
 Median 95% CI Reference range
b
 P 
Ht
c
 0.35 0.32-0.37 0.34 0.31-0.36 0.32-0.48 l/l 0.133 
Hb
d
 129.50 120.25-137.75 124.00 115.50-132.50 100-180 g/l 0.069 
RBCC
e
 8.89 8.39-9.52 8.42 7.92-8.97 6.0-12.0 x 10
12
 cells/l 0.001
*
 
WBCC
f
 9.80 7.93-11.18 9.20 7.45-11.10 6.0-12.0 x 10
9
 cells/l 0.700 
MCV
g
 38.20 35.23-42.98 38.80 36.20-43.90 34-58 fl 0.187 
MCH
h
 14.65 13.23-15.80 14.70 13.60-16.30 13-19 pg 0.301 
MCHC
i
 37.50 36.60-38.18 37.00 36.95-37.80 31-37 g/dl 0.029
*
 
 PCR negative, > 1 year (n = 64) PCR positive, > 1 year (n = 23)   
Parameter Median 95% CI Median 95% CI Reference range P 
Ht 0.36 0.34-0.38 0.35 0.34-0.37 0.32-0.48 l/l 0.196 
Hb 133.00 126.00-140.00 129.00 124.00-135.50 100-180 g/l 0.105 
RBCC 8.81 8.29-9.25 8.42 7.95-8.94 6.0-12.0 x 10
12
 cells/l 0.094 
WBCC 9.30 7.58-10.93 8.30 7.35-10.75 6.0-12.0 x 10
9
 cells/l 0.652 
MCV 40.90 37.18-43.95 42.40 37.35-45.85 34-58 fl 0.275 
MCH 15.30 14.20-15.95 15.10 14.15-16.60 13-19 pg 0.381 
MCHC 37.30 36.40-38.20 37.00 36.15-37.80 31-37 g/dl 0.069 
 PCR negative, < 1 year (n = 22) PCR positive, < 1 year (n = 8)   
Parameter Median 95% CI Median 95% CI Reference range P 
Ht 0.31 0.30-0.33 0.30 0.29-0.31 0.32-0.48 l/l 0.023
*
 
Hb 118.50 111.25-123.00 110.50 106.75-113.75 100-180 g/l 0.021
*
 
RBCC 9.41 8.82-9.86 8.43 7.84-9.06 6.0-12.0 x 10
12
 cells/l 0.013
*
 
WBCC 10.75 9.80-11.65 11.25 8.80-11.68 6.0-12.0 x 10
9
 cells/l 0.593 
MCV 33.35 32.55-34.53 34.55 34.18-36.80 34-58 fl 0.021
*
 
MCH 12.60 12.33-12.90 13.15 12.90-13.23 13-19 pg 0.015
*
 
MCHC 37.75 37.10-38.08 37.25 36.15-38.03 31-37 g/dl 0.174 
Results of hematological analysis are shown for all horses and for horses grouped according to their age (> 1 year; < 1 year); 
a
 confidence interval; 
b
 Reference range according to 16 
Cowell and Tyler, 2001;
c
 hematocrit; 
d
 hemoglobin; 
e
 red blood cell count, 
f
 white blood cell count; 
g
 mean cell volume, 
h
 mean cell hemoglobin, 
i
 mean cell hemoglobin 17 
concentration, 
*
 significant if  P  0.05. 18 
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